Insider: Poulton Jeffrey V. EVP, Chief Financial Officer - ALNYLAM PHARMACEUTICALS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 52,185 | 0 | 52,185 |
| Value | $23,295,384.00 | $0.00 | $23,295,384.00 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/18/2025 | DDS | 147 | Direct | COM | $449.92 | $66,138.24 | 52,185 |
| 08/18/2025 | DDS | 63 | Direct | COM | $447.98 | $28,222.74 | 52,332 |
| 08/18/2025 | DDS | 19 | Direct | COM | $455.82 | $8,660.58 | 50,121 |
| 08/18/2025 | DDS | 168 | Direct | COM | $451.99 | $75,934.32 | 51,954 |
| 08/18/2025 | DDS | 63 | Direct | COM | $450.92 | $28,407.96 | 52,122 |
| 08/18/2025 | DDS | 392 | Direct | COM | $454.84 | $178,297.28 | 50,140 |
| 08/18/2025 | DDS | 886 | Direct | COM | $454.04 | $402,279.44 | 50,532 |
| 08/18/2025 | DDS | 536 | Direct | COM | $452.96 | $242,786.56 | 51,418 |
| 03/03/2025 | DDS | 382 | Direct | COM | $243.36 | $92,963.52 | 48,283 |
| 03/03/2025 | DDS | 350 | Direct | COM | $242.37 | $84,829.50 | 48,665 |
| 03/03/2025 | DDS | 258 | Direct | COM | $244.41 | $63,057.78 | 48,025 |
| 03/03/2025 | DDS | 7 | Direct | COM | $247.35 | $1,731.45 | 47,752 |
| 03/03/2025 | DDS | 189 | Direct | COM | $245.26 | $46,354.14 | 47,836 |
| 03/03/2025 | DDS | 1 | Direct | COM | $248.36 | $248.36 | 47,751 |
| 03/03/2025 | DDS | 77 | Direct | COM | $246.18 | $18,955.86 | 47,759 |
| 02/28/2025 | DDS | 35 | Direct | COM | $239.18 | $8,371.30 | 34,583 |
| 02/28/2025 | DDS | 34 | Direct | COM | $238.33 | $8,103.22 | 34,618 |
| 02/28/2025 | DDS | 42 | Direct | COM | $236.51 | $9,933.42 | 34,652 |
| 02/28/2025 | DDS | 78 | Direct | COM | $240.32 | $18,744.96 | 34,505 |
| 02/28/2025 | DDS | 127 | Direct | COM | $241.51 | $30,671.77 | 34,378 |
| 02/28/2025 | DDS | 59 | Direct | COM | $244.11 | $14,402.49 | 33,898 |
| 02/28/2025 | DDS | 121 | Direct | COM | $243.23 | $29,430.83 | 33,957 |
| 02/28/2025 | DDS | 300 | Direct | COM | $242.44 | $72,732.00 | 34,078 |
| 02/14/2025 | DDS | 68 | Direct | COM | $255.56 | $17,378.08 | 33,069 |
| 02/14/2025 | DDS | 78 | Direct | COM | $256.29 | $19,990.62 | 32,991 |
| 1 2 3 Next Last You are at page 1 of 3 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research